Go Pro

Nuvalent (NUVL) 10K Form and Latest SEC Filings 2026

Nuvalent logo
$123.80 +0.08 (+0.06%)
As of 11:50 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Nuvalent SEC Filings & Recent Activity

Nuvalent (NASDAQ:NUVL) has submitted 417+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Nuvalent's financial statements. The most recent filing was a Form 4 submitted on July 6, 2026.

Form 4
Nuvalent, Inc. Reports Ownership Change on Jul. 6, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Nuvalent Files Current Report on Jun. 18, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Nuvalent Files Quarterly Report on May. 7, 2026

The 10-Q contains Nuvalent's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Nuvalent SEC Filing History

Browse Nuvalent's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
07/06/2026 3:30 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 3:31 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2026 3:03 PM
GSK plc (1131399) Filed by
Nuvalent (1861560) Subject
Form SC TO-T/A
06/24/2026 7:02 AM
Nuvalent (1861560) Subject
Form SC 14D9
06/24/2026 6:15 AM
GSK plc (1131399) Filed by
Nuvalent (1861560) Subject
Form SC TO-T
06/18/2026 5:35 PM
DEERFIELD MANAGEMENT COMPANY, L.P. (1009258) Reporting
Flynn James E (1352546) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:30 PM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2026 3:32 PM
Bogle Grant C. (1646675) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:32 PM
Meyers Michael L. (1664204) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:33 PM
Nuvalent (1861560) Issuer
Oliger Christy J. (1822092) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:33 PM
Nuvalent (1861560) Issuer
Protopapas Anna (1347582) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:34 PM
Nuvalent (1861560) Issuer
Squarer Ron (1454001) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:35 PM
Nuvalent (1861560) Issuer
Srivastava Sapna (1569226) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:35 PM
Nuvalent (1861560) Issuer
Wheeler Cameron (1735323) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2026 3:30 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 3:54 PM
GSK plc (1131399) Filed by
Nuvalent (1861560) Subject
Form SC TO-C
06/10/2026 3:30 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2026 4:18 PM
Nuvalent (1861560) Subject
Form SC14D9C
06/09/2026 4:20 PM
GSK plc (1131399) Filed by
Nuvalent (1861560) Subject
Form SC TO-C
06/09/2026 3:04 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2026 6:13 AM
GSK plc (1131399) Filed by
Nuvalent (1861560) Subject
Form SC TO-C
06/09/2026 6:03 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2026 3:03 PM
Nuvalent (1861560) Subject
Porter James Richard (1862900) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 3:30 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 3:31 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2026 5:38 AM
Nuvalent (1861560) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 5:35 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 3:30 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 10:30 AM
FMR LLC (315066) Filed by
Nuvalent (1861560) Subject
Form SCHEDULE 13G/A
05/01/2026 3:30 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 3:30 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2026 3:30 PM
Nuvalent (1861560) Filer
Form ARS
04/13/2026 3:30 PM
Nuvalent (1861560) Issuer
Pelish Henry E. (2029477) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 3:30 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2026 5:33 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2026 3:30 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:30 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2026 3:30 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 5:32 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2026 3:30 PM
Lane Benjamin (2120762) Reporting
Nuvalent (1861560) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/10/2026 3:30 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
03/02/2026 3:32 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 5:49 AM
Nuvalent (1861560) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2026 5:35 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2026 5:39 AM
Nuvalent (1861560) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/17/2026 3:45 PM
Nuvalent (1861560) Subject
Shair Matthew (1862123) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2026 1:16 PM
Flynn James E (1352546) Filed by
Nuvalent (1861560) Subject
Form SCHEDULE 13G/A
01/22/2026 3:33 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2026 5:30 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 4:25 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 4:25 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 4:26 PM
Nuvalent (1861560) Issuer
Turner Christopher Durant (1862146) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 4:26 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 4:26 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 4:27 PM
Nuvalent (1861560) Issuer
Pelish Henry E. (2029477) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 7:54 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 7:55 PM
Nuvalent (1861560) Subject
Turner Christopher Durant (1862146) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 7:57 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 7:58 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 7:58 PM
Nuvalent (1861560) Subject
Pelish Henry E. (2029477) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 7:53 PM
Nuvalent (1861560) Subject
Porter James Richard (1862900) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2026 3:20 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:30 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:30 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:31 PM
Nuvalent (1861560) Issuer
Pelish Henry E. (2029477) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2025 6:51 AM
Nuvalent (1861560) Filer
Form S-3ASR
12/16/2025 9:06 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 3:30 PM
Nuvalent (1861560) Issuer
Squarer Ron (1454001) Reporting
Form 3
Initial statement of beneficial ownership of securities  
12/11/2025 3:31 PM
Nuvalent (1861560) Issuer
Squarer Ron (1454001) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 3:30 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 7:36 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2025 3:30 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2025 3:30 PM
Nuvalent (1861560) Issuer
Shair Matthew (1862123) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 7:00 PM
Deerfield Healthcare Innovations Fund, L.P. (1646981) Reporting
DEERFIELD MANAGEMENT COMPANY, L.P. (1009258) Reporting
Deerfield Mgmt HIF, L.P. (1665736) Reporting
Deerfield Mgmt IV, L.P. (1713467) Reporting
Deerfield Mgmt L.P. (1010823) Reporting
DEERFIELD PARTNERS, L.P. (1301041) Reporting
Deerfield Private Design Fund IV, L.P. (1680307) Reporting
Flynn James E (1352546) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 5:01 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2025 4:13 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 4:14 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:53 PM
Nuvalent (1861560) Filer
Form 424B5
11/17/2025 3:37 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2025 3:09 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2025 3:05 PM
Nuvalent (1861560) Filer
Form 424B5
11/17/2025 5:36 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 3:16 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2025 5:37 AM
Nuvalent (1861560) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 5:42 AM
Nuvalent (1861560) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2025 3:31 PM
Nuvalent (1861560) Issuer
Shair Matthew (1862123) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 3:06 PM
Nuvalent (1861560) Subject
Shair Matthew (1862123) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/27/2025 3:09 PM
Nuvalent (1861560) Subject
Shair Matthew (1862123) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2025 3:32 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 3:31 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 3:31 PM
Nuvalent (1861560) Issuer
Pelish Henry E. (2029477) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
10/17/2025 3:32 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 3:32 PM
Nuvalent (1861560) Issuer
Porter James Richard (1862900) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2025 3:02 PM
Nuvalent (1861560) Subject
Porter James Richard (1862900) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2025 3:30 PM
Nuvalent (1861560) Issuer
Pelish Henry E. (2029477) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2025 3:30 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2025 3:37 PM
Miller Deborah Ann (1868741) Reporting
Nuvalent (1861560) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/14/2025 6:43 AM
Nuvalent (1861560) Subject
Pelish Henry E. (2029477) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025 3:28 PM
Balcom Alexandra (1862147) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2025 7:14 PM
Noci Darlene (1862148) Reporting
Nuvalent (1861560) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Nuvalent SEC Filings - Frequently Asked Questions

Nuvalent (NUVL) has submitted 417+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

Nuvalent's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Nuvalent's financial statements page.

The most recent filing was a Form 4 submitted on July 6, 2026. This was an insider ownership change filed by 4 - Nuvalent, Inc. (0001861560) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:NUVL) was last updated on 7/7/2026 by MarketBeat.com Staff.
From Our Partners